605 related articles for article (PubMed ID: 23891975)
21. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
Papay P; Reinisch W; Ho E; Gratzer C; Lissner D; Herkner H; Riss S; Dejaco C; Miehsler W; Vogelsang H; Novacek G
Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
[TBL] [Abstract][Full Text] [Related]
22. Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study.
Vos AC; Bakkal N; Minnee RC; Casparie MK; de Jong DJ; Dijkstra G; Stokkers P; van Bodegraven AA; Pierik M; van der Woude CJ; Oldenburg B; Hommes DW;
Inflamm Bowel Dis; 2011 Sep; 17(9):1837-45. PubMed ID: 21830262
[TBL] [Abstract][Full Text] [Related]
23. Azathioprine and mercaptopurine: lymphoma.
Prescrire Int; 2011 May; 20(116):126. PubMed ID: 21648178
[TBL] [Abstract][Full Text] [Related]
24. Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study.
Prieux-Klotz C; Nahon S; Amiot A; Sinayoko L; Galéano-Cassaz C; Chaussade S; Coriat R; Lahmek P; Abitbol V
Dig Dis Sci; 2017 Feb; 62(2):473-480. PubMed ID: 27853898
[TBL] [Abstract][Full Text] [Related]
25. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
26. Increased risk of acute myeloid leukemias and myelodysplastic syndromes in patients who received thiopurine treatment for inflammatory bowel disease.
Lopez A; Mounier M; Bouvier AM; Carrat F; Maynadié M; Beaugerie L; Peyrin-Biroulet L;
Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1324-9. PubMed ID: 24582568
[TBL] [Abstract][Full Text] [Related]
27. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
[TBL] [Abstract][Full Text] [Related]
28. Minimal risk of lymphoma and non-melanoma skin cancer despite long-term use of thiopurines in patients with inflammatory bowel disease: A longitudinal cohort analysis from northern India.
Ranjan MK; Kante B; Vuyyuru SK; Kumar P; Mundhra SK; Golla R; Sharma R; Sahni P; Das P; Makharia G; Kedia S; Ahuja V
J Gastroenterol Hepatol; 2022 Aug; 37(8):1544-1553. PubMed ID: 35501287
[TBL] [Abstract][Full Text] [Related]
29. Recent advances using immunomodulators for inflammatory bowel disease.
Nielsen OH; Bjerrum JT; Herfarth H; Rogler G
J Clin Pharmacol; 2013 Jun; 53(6):575-88. PubMed ID: 23408468
[TBL] [Abstract][Full Text] [Related]
30. Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.
Daperno M; Sostegni R; Canaparo R; Serpe L; Lavagna A; Crocellà L; Castagno F; Vernetto A; Rigazio C; Ercole E; D'Antico S; Pera A; Zara G; Rocca R
Aliment Pharmacol Ther; 2009 Oct; 30(8):843-53. PubMed ID: 19650826
[TBL] [Abstract][Full Text] [Related]
31. Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal.
Moreno-Rincón E; Benítez JM; Serrano-Ruiz FJ; Vázquez-Morón JM; Pallarés-Manrique H; Herrera-Justiniano JM; Leo-Carnerero E; Gómez-García MR; Cabello-Tapia MJ; Castro-Fernández M; Rojas-Feria M; Castro-Laria L; Argüelles-Arias F; Camargo-Camero R; Alcaín-Martínez G; Iglesias-Flores E; García-Sánchez V
Inflamm Bowel Dis; 2015 Jul; 21(7):1564-71. PubMed ID: 26070002
[TBL] [Abstract][Full Text] [Related]
32. Lymphoma: the bête noire of the long-term use of thiopurines in adult and elderly patients with inflammatory bowel disease.
Beaugerie L
Gastroenterology; 2013 Nov; 145(5):927-30. PubMed ID: 24070724
[No Abstract] [Full Text] [Related]
33. Elderly-Onset and Adult-Onset Ulcerative Colitis Are More Similar than Previously Reported in a Nationwide Cohort.
Kumar V; Shah Y; Patel D; Khan N
Dig Dis Sci; 2017 Oct; 62(10):2857-2862. PubMed ID: 28884254
[TBL] [Abstract][Full Text] [Related]
34. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine.
Korelitz BI; Mirsky FJ; Fleisher MR; Warman JI; Wisch N; Gleim GW
Am J Gastroenterol; 1999 Nov; 94(11):3248-53. PubMed ID: 10566724
[TBL] [Abstract][Full Text] [Related]
35. Adherence and efficacy of screening for low bone mineral density among ulcerative colitis patients treated with corticosteroids.
Khan N; Abbas AM; Almukhtar RM; Cole EB; Khan AN
Am J Gastroenterol; 2014 Apr; 109(4):572-8. PubMed ID: 24469613
[TBL] [Abstract][Full Text] [Related]
36. Clinical predictors of thiopurine-related adverse events in Crohn's disease.
Moran GW; Dubeau MF; Kaplan GG; Yang H; Eksteen B; Ghosh S; Panaccione R
World J Gastroenterol; 2015 Jul; 21(25):7795-804. PubMed ID: 26167079
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines.
Walch A; Meshkat M; Vogelsang H; Novacek G; Dejaco C; Angelberger S; Mikulits A; Miehsler W; Gangl A; Reinisch W
J Crohns Colitis; 2010 Oct; 4(4):398-404. PubMed ID: 21122535
[TBL] [Abstract][Full Text] [Related]
38. Outcome of concomitant treatment with thiopurines and allopurinol in patients with inflammatory bowel disease: A nationwide Danish cohort study.
Thomsen SB; Allin KH; Burisch J; Jensen CB; Hansen S; Gluud LL; Theede K; Kiszka-Kanowitz M; Nielsen AM; Jess T
United European Gastroenterol J; 2020 Feb; 8(1):68-76. PubMed ID: 32213059
[TBL] [Abstract][Full Text] [Related]
39. The use of thiopurines for the treatment of inflammatory bowel diseases in clinical practice.
Saibeni S; Virgilio T; D'Incà R; Spina L; Bortoli A; Paccagnella M; Peli M; Sablich R; Meucci G; Colombo E; Benedetti G; Girelli CM; Casella G; Grasso G; de Franchis R; Vecchi M
Dig Liver Dis; 2008 Oct; 40(10):814-20. PubMed ID: 18479986
[TBL] [Abstract][Full Text] [Related]
40. Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.
Lemaitre M; Kirchgesner J; Rudnichi A; Carrat F; Zureik M; Carbonnel F; Dray-Spira R
JAMA; 2017 Nov; 318(17):1679-1686. PubMed ID: 29114832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
